Pillar Biosciences
Pillar Biosciences


Natick, MA, USA · North America


Biotechnology · DeepTech · Health


51-200 employees


Series C+

founded in


Pillar Biosciences is prized with its patent-pending targeted sequencing technology platform and a proprietary data analysis toolkit, which achieves high sensitivity and specificity with clinical samples. The platform provides a fast, simple and affordable targeted sequencing method for NGS-based oncology testing. The start-up has also released its beta version of Lung & Colon Cancer Somatic Mutation Panel and BRCA1 & BRCA2 Germline Mutation Panel to cancer centers and clinical testing companies in the US and China for validation studies. The company was founded in 2014 and is headquartered in Natick, Massachusetts.

Something looks off?
Open jobs at Pillar Biosciences

On-site & Remote